Can prednisolone ophthalmic drops cause blurred vision in one eye?

Can Prednisolone Eye Drops Cause Unilateral Blurred Vision?

Yes, prednisolone ophthalmic drops can cause blurred vision in one or both eyes—this is a recognized adverse effect listed in the FDA drug label. 1

Mechanism and Clinical Presentation

Blurred vision from prednisolone eye drops occurs through several pathways:

• Direct transient effect: Visual disturbance (blurry vision) is explicitly listed as an adverse reaction to prednisolone acetate ophthalmic suspension, often occurring as transient burning and stinging upon instillation with associated minor ocular irritation. 1

• Steroid-induced intraocular pressure elevation: Prednisolone can elevate IOP, potentially leading to glaucoma development and optic nerve damage, which manifests as progressive vision loss. 1 The risk increases significantly when dosing ≥2 drops per eye per day. 2, 3

• Cataract formation: Posterior subcapsular cataract formation is a well-documented complication of topical corticosteroids, causing gradual vision impairment. 1 Risk escalates with dosing ≥4 drops per eye per day. 2, 3

• Corneal complications: Delayed wound healing and development of corneal ulceration can occur, particularly with prolonged use, contributing to visual symptoms. 1

Unilateral vs. Bilateral Presentation

Blurred vision can absolutely occur unilaterally if:

• The drops are applied to only one eye
• One eye has greater susceptibility to steroid-induced IOP elevation (steroid responders vary individually)
• Pre-existing ocular conditions in one eye make it more vulnerable to steroid effects
• Dosing frequency differs between eyes

The FDA label does not restrict adverse effects to bilateral presentation—any treated eye can develop complications. 1

Critical Safety Considerations

Avoid prednisolone in these scenarios:

• Acute untreated purulent ocular infections 1
• Viral diseases including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella 1
• Mycobacterial or fungal eye infections 1
• Known hypersensitivity to corticosteroids 1

Starting steroids before proper eye examination may worsen infectious conditions (e.g., herpetic keratitis) or mask accurate diagnosis. 4

Monitoring Requirements

For any patient using prednisolone eye drops:

• Baseline ophthalmologic examination including IOP measurement is recommended before initiating therapy. 5

• Periodic IOP measurements are mandatory during treatment, as nearly two-thirds of patients on long-term corticosteroids may develop raised IOP, often asymptomatically. 5

• Cataract screening should occur with prolonged use, as posterior subcapsular cataracts develop characteristically with long-term glucocorticoid therapy. 6

• For patients on stable topical therapy: ophthalmologic examinations at least every 3 months. 3

• When tapering or stopping: ophthalmologic assessment within 1 month of each change. 3

Duration and Dosing Pitfalls

Common errors leading to vision complications:

• Prolonged use without monitoring: Increases risk of steroid-induced glaucoma and cataract formation. 3, 7

• Self-medication without physician knowledge: One case report documented a patient using tobramycin/dexamethasone drops for 3.5 years without medical supervision, resulting in advanced optic disc cupping, tunnel vision, and near-irreversible blindness from steroid-induced glaucoma. 7

• Exceeding 3 months of therapy: If ≥1-2 drops per eye per day are needed for ≥3 months, systemic immunomodulatory therapy should be added or intensified to allow steroid discontinuation. 3

• Failure to taper appropriately: May cause rebound inflammation. 3

Clinical Bottom Line

If a patient presents with unilateral blurred vision while using prednisolone eye drops, immediately:

1. Measure IOP in both eyes to assess for steroid-induced glaucoma 5, 3
2. Perform slit-lamp examination for cataract formation 5
3. Evaluate for corneal complications or infectious keratitis 1
4. Review duration and frequency of steroid use 2, 3
5. Consider discontinuation or dose reduction if complications identified 7

The blurred vision may resolve with cessation of drops and appropriate antiglaucoma therapy if caught early, but prolonged unrecognized steroid-induced glaucoma can cause irreversible blindness. 7